Carregant...
Dengue vaccine development: status and future
Dengue, the most common arbovirus, represents an increasingly significant cause of morbidity worldwide, including in travelers. After decades of research, the first dengue vaccine was licensed in 2015: CYD-TDV, a tetravalent live attenuated vaccine with a yellow fever vaccine backbone. Recent analys...
Guardat en:
| Publicat a: | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7224137/ https://ncbi.nlm.nih.gov/pubmed/31784763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00103-019-03060-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|